Name: Point-of-care Molecular Diagnostics Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment &amp; Forecast (2023-2030)
SKU: 17208
Availability: InStock

Point-of-care Molecular Diagnostics Market – Report Overview

Pacific Business Consulting’s “Point-of-care Molecular Diagnostics Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of Point-of-care Molecular Diagnostics market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

The Point-of-care Molecular Diagnostics market, surpassing a valuation of US$ 5.4 Billion in 2022, is positioned for significant growth, with a projected Compound Annual Growth Rate (CAGR) exceeding 6.0% from 2023 to 2030, potentially reaching beyond US$ 9.0 Billion by 2030.

The increasing prevalence of chronic and infectious diseases, along with genetic disorders such as Alzheimer’s disease, Turner syndrome, and Parkinson’s disease, is expected to drive market demand during the forecast period. Continuous improvement in product quality contributes significantly to market growth. Additionally, the rising demand for rapid tests, coupled with numerous new product introductions in point-of-care (POC) molecular diagnostics, is anticipated to fuel market growth.

POC molecular diagnostics in primary care settings cover a spectrum from simple glucose testing to complex coagulation testing. The transition from conventional lab testing to POC testing in various clinics is gaining traction, reducing the time required to decide whether further tests are necessary by eliminating delays in specimen preparation and transport. The advantages of POC molecular diagnostics include rapid result availability, cost-effectiveness, and improved outcomes. The market has experienced substantial growth, particularly in the U.S. and European countries, driven by increased awareness regarding medical and organizational concerns and the economic advantages of point-of-care testing.

Aging is a significant factor influencing cancer development, with nearly two-thirds of all new cancer cases diagnosed in individuals aged 65 and above. Molecular diagnostics play a crucial role in managing cancer, infectious diseases, and cardiovascular diseases, making them vital for public health surveillance and detection. The growing geriatric population is expected to contribute to market growth.

Market players are actively involved in developing novel POC testing products to capitalize on market opportunities. For example, Huwel Lifesciences designed a portable RT-PCR machine capable of testing various viruses, providing results within 30 minutes using blood and gastrointestinal samples. Additionally, Curative, Inc. announced the spin-off of Sensible Diagnostics in April 2023, focusing on a novel POC PCR testing platform providing accurate results within 10 minutes.

Factors contributing to market growth include the rising prevalence of chronic and infectious diseases, expansion of the laboratory sector due to increased adoption of POC molecular diagnostics by healthcare manufacturers, high costs, delays, and time-consuming methods driving demand, increasing diagnostic tests and preventive medicine, adoption of modern techniques, growing demand for DNA sequencing and multi-gene examination, rapid and accurate results, and the expansion of POC molecular diagnostics applications to detect gastrointestinal disorders and respiratory and sexually transmitted diseases. Growing patient awareness in emerging economies and advancements in microfluidics, government initiatives, and manufacturer developments also present market opportunities.

However, factors such as a lack of awareness about health and healthcare products in developing countries, absence of reimbursement policies, and poor penetration of advanced healthcare devices may limit market growth in certain regions.

Key players in the Point-of-care Molecular Diagnostics segment, including Quidel Corporation, QIAGEN N.V., Co-Diagnostics, Inc., Biocartis NV, Meridian Bioscience, Inc., Thermo Fisher Scientific, Inc., Abbott Laboratories, Hoffmann-La Roche Ltd., BioMérieux S.A., and Danaher Corporation, are expected to play a pivotal role in shaping the future landscape of Point-of-care Molecular Diagnostics technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Point-of-care Molecular Diagnostics market. It also delves into the analysis of present and prospective market competition within the global Point-of-care Molecular Diagnostics market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

Develop your business strategies by gaining insights into the trends that shape and drive the Point-of-care Molecular Diagnostics market across the 10MM (Ten Major Markets).
Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM Point-of-care Molecular Diagnostics market.
Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

Executive Summary: Point-of-Care Molecular Diagnostics
- Global Market Outlook: Point-of-Care Molecular Diagnostics
Competitive Intelligence Analysis: Point-of-Care Molecular Diagnostics
Therapeutic Sector SWOT
Technology Roadmap Analysis: Point-of-Care Molecular Diagnostics
Market Background
- Drivers
- Restraints
- Opportunity
- Key Market Trends
- Key Unmet Needs
Key Marketed Products Profile – Major Approved Products: Point-of-Care Molecular Diagnostics
- Product Profile
- Safety and Efficacy
Regulatory Landscape
Point-of-Care Molecular Diagnostics: Ten Major Market (10MM) – Market Analysis, By Technology
- Genetic Sequencing-based
- PCR-based
- Microarray-based
- Hybridization-based
- Others
Point-of-Care Molecular Diagnostics: Ten Major Market (10MM) – Market Analysis, By Application
- Oncology
- Prenatal Testing
- Endocrinology
- Hematology
- Infectious Diseases
- Others
Point-of-Care Molecular Diagnostics: Ten Major Market (10MM) – Market Analysis, By End User
- Hospitals & ICUs
- Physicians’ Offices
- Academic & Research Institutions
- Other End Users
Point-of-Care Molecular Diagnostics: Ten Major Market (10MM) – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Technology
  - By Application
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Technology
  - By Application
  - By End User

S. Point-of-Care Molecular Diagnostics – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Technology
  - By Application
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Technology
  - By Application
  - By End User

K. Point-of-Care Molecular Diagnostics – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Technology
  - By Application
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Technology
  - By Application
  - By End User

Germany Point-of-Care Molecular Diagnostics – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Technology
  - By Application
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Technology
  - By Application
  - By End User

France Point-of-Care Molecular Diagnostics – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Technology
  - By Application
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Technology
  - By Application
  - By End User

Italy Point-of-Care Molecular Diagnostics – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Technology
  - By Application
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Technology
  - By Application
  - By End User

Spain Point-of-Care Molecular Diagnostics – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Technology
  - By Application
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Technology
  - By Application
  - By End User

Japan Point-of-Care Molecular Diagnostics – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Technology
  - By Application
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Technology
  - By Application
  - By End User

China Point-of-Care Molecular Diagnostics – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Technology
  - By Application
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Technology
  - By Application
  - By End User

Australia Point-of-Care Molecular Diagnostics – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Technology
  - By Application
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Technology
  - By Application
  - By End User

India Point-of-Care Molecular Diagnostics – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Technology
  - By Application
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Technology
  - By Application
  - By End User

Competitive Landscape
- Company Overview
- Product Portfolio
- Key Financials
- Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

Assumptions and Acronyms Used
Research Methodology
- Secondary Research
- Primary Research
- Data Triangulation
Geographic Scope
- The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
Copyrights and Disclaimer

Point-of-care Molecular Diagnostics Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)

License Type (Price in USD)

Customize Reports As Per Your Needs

Have A Question?

Phone:+919599779105
Email:info@pacificbusinessconsulting.com

RELATED PRODUCTS

Diabetes Mellitus (DM) Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment and Forecast (2023-2030)

Heart Failure (HF) Market in United States, United Kingdom– Market Insights, Unmet Needs, Market Assessment and Forecast (2023-2030)

Metastatic Prostate Cancer Market in United States, United Kingdom– Market Insights, Market Assessment and Market Forecast (2023-2030)

Multiple Sclerosis Market in United States, United Kingdom – Market Outlook, Unmet Needs, Market Assessment and Forecast (2023-2030)

Obesity Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment and Forecast (2023-2030)

Useful Links

Consulting

Get In Touch